CBS 2019
CBSMD教育中心
English

肺动脉高压

科研文章

荐读文献

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist? Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study Pulmonary Artery Denervation: An Alternative Therapy for Pulmonary Hypertension Active and Passive Vaccination for Pulmonary Arterial Hypertension: A Novel Therapeutic Paradigm Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial Chronic thromboembolic pulmonary hypertension Left main coronary artery compression in pulmonary hypertension

Clinical Trial2006 Jul 4;114(1):48-54.

JOURNAL:Circulation. Article Link

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study

Galiè N, Beghetti M, Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Keywords: pulmonary hypertension; invasive screening; congenital heart disease; peak oxygen uptake

FULL TEXT PDF